Cadila Healthcare has informed that it has enclosed a copy of press release dated April 23, 2021 titled ‘Zydus Cadila receives final approval from USFDA for Propafenone Hydrochloride Extended-Release Capsules’. The contents of the press release give full details.
The above information is a part of company’s filings submitted to BSE.